New physiological effects of the incretin hormones GLP-1 and GIP.


With approximately 400 million people worldwide today being obese, we are facing a major public health problem due to the increasing prevalence of the related comorbidities such as type 2 diabetes, hypertension and coronary heart disease. To date, pharmacological treatment of obesity has been largely unsuccessful, only achieving modest and short-lasting… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.